Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells

Yang Yang1, Xiaolong Yan, Weixun Duan

  • 1Department of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an City, China.

Plos One
|May 15, 2013
PubMed

Insights

Pterostilbene (PTE) shows antitumor effects against lung cancer by increasing cell death and reactive oxygen species. Inhibiting Notch1 signaling enhances PTE

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pterostilbene (PTE) exhibits potent antitumor properties, but its precise molecular mechanisms are not fully understood.
  • Lung adenocarcinoma is a significant global health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the antitumor activity of PTE against human lung adenocarcinoma.
  • To elucidate the role of the Notch1 signaling pathway in PTE's anticancer effects.

Main Methods:

  • In vitro and in vivo studies using A549 lung adenocarcinoma cells.
  • Assessment of cell viability, mitochondrial membrane potential (MMP), glutathione levels, reactive oxygen species (ROS), and apoptosis.
  • Analysis of Notch1 Intracellular Domain (NICD) and Hes1 activation.
  • Utilized DAPT (gamma secretase inhibitor) and Notch1 siRNA to modulate Notch signaling.

Main Results:

  • PTE reduced lung adenocarcinoma cell viability in a dose- and time-dependent manner.
  • PTE induced apoptosis, increased ROS, decreased MMP, and reduced glutathione levels.
  • PTE activated Notch1 signaling (NICD and Hes1), which was inhibited by DAPT and Notch1 siRNA.
  • Notch1 inhibition sensitized cells to PTE and blocked pro-survival PI3K/Akt pathway activation.

Conclusions:

  • Lung adenocarcinoma cells activate Notch1 signaling as a survival response to PTE treatment.
  • Combining PTE with a gamma secretase inhibitor may offer a novel therapeutic strategy for lung adenocarcinoma by targeting cancer cell survival pathways.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...